Associate Professor Andrew Vallely is a medically-trained epidemiologist who has led multi-disciplinary research teams in developing countries for over 15 years in the epidemiology and prevention of HIV, sexually transmitted and other infectious diseases. In 2007, he established an international collaborative research group in sexual and reproductive health at the Papua New Guinea Institute of Medical Research (PNG IMR), where he was Head of the Sexual and Reproductive Health Unit and Deputy Director from 2010-2015. His collaborative research group recently completed an intervention study among 1000 women in PNG, which demonstrated excellent agreement between self-collected vaginal specimens and clinician-collected cervical specimens for the detection of high-risk HPV infection using the Xpert HPV Test. In this study, point-of-care Xpert HPV testing using self-collected specimens outperformed visual inspection of the cervix with acetic acid (VIA), or a combination of HPV testing plus VIA, for the detection of underlying high-grade squamous intraepithelial lesions (HSIL). His group is currently conducting a field trial among 3400 women in PNG to confirm these initial findings, and to evaluate the cost-effectiveness, health system implementation requirements and acceptability of this point-of-care Xpert HPV ‘test and treat’ strategy. Dr Vallely also leads a UK Wellcome Trust / NHMRC co-funded cluster randomised trial in PNG to evaluate antenatal point-of-care testing and treatment of sexually transmitted infections to improve birth outcomes in high-burden, low-resource settings (WANTAIM Trial); and is a lead investigator on an intervention trial to evaluate point-of-care Xpert HIV testing to accelerate ART initiation among HIV-exposed infants in PNG and Myanmar (AAMI Study).